LIB Therapeutics
OrganisationROR
Trials
Phase 3Completed2022166 people13 Aug 2021clinicaltrials.gov
Phase 3Completed2021204 people10 Mar 2021clinicaltrials.gov
Phase 3Completed201965 people26 Jul 2019clinicaltrials.gov
OrganisationROR
Phase 3Completed2022166 people13 Aug 2021clinicaltrials.gov
Phase 3Completed2021204 people10 Mar 2021clinicaltrials.gov
Phase 3Completed201965 people26 Jul 2019clinicaltrials.gov